Denemek ALTIN - Özgür
Principles and applications of Chromatography & HPLC
Chronicle Pharmabiz
|September 18, 2025
HIGH-performance liquid chromatography (HPLC) is an important instrument used in the pharmaceutical industry for evaluations and quality control of a large variety of samples.
It is a chromatographic method that is used to separate a mixture of compounds in analytical chemistry, biochemistry and especially in pharmaceutical industries so as to identify, quantify or purify the individual components of the mixture. It is a method of choice for checking purity of new chemical entities, monitoring changes in synthetic procedures or scale up, evaluating new formulations, and carrying out quality control and the assurance of the final drug product. The present article gives a brief overview of modern HPLC method development especially for pharma industry.
Rapid high-performance liquid chromatography method could improve formulation quality control studies. Researchers say the novel high-performance liquid chromatography with diode-array detection method can be utilised in routine quality control analysis of levofloxacin in pharmaceutical formulation and bioequivalence studies.
Chromatography and HPLC
Selectivity and detectability optimization are the primary goals in HPLC separations. The separation principle of HPLC is based on the distribution of the analyte (sample) between a mobile phase; called eluent and a stationary phase; usually the packing material of the column, which is stationery. Depending on the chemical structure of the analyte, the molecules are retarded while passing the stationary phase.
In gas chromatography (GC), the mobile phase is a gas and the analytes need to have sufficient volatility to pass through the column. In addition, the analytes need to be stable at the temperatures exposed to in the injector and/or in the column. Analytes that are not volatile, for example, fatty acids, can be made volatile by derivatization, e.g., the fatty acids can be converted to esters.
Bu hikaye Chronicle Pharmabiz dergisinin September 18, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Chronicle Pharmabiz'den DAHA FAZLA HİKAYE
Chronicle Pharmabiz
Devices sector raises concern over notification proposing fee for tests
THE medical devices industry has raised concern over the Department of Health and Family Welfares' draft notification introducing fee for test or evaluation of medical devices and mandating inclusion of licence number of sub contractor on the product labels. The Department published the draft notification on April 10, proposing various amendments to the Medical Devices Rules (MDR), 2017 including introduction of fee for test or evaluation of 11 types of tests or evaluation.
2 mins
April 30, 2026
Chronicle Pharmabiz
Panel asks DoP to take efforts to decrease imported content in medical devices
OBSERVING that a majority of the medical devices market is addressed by imports, the Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DOP) to take measures including promotion of stronger collaboration among the industry, academic institutions and research organisations to accelerate indigenous development of advanced medical devices.
1 mins
April 30, 2026
Chronicle Pharmabiz
AI in endoscopy will improve detecting early-stage cancer markers
INDIA has been moving steadily towards better cancer care. However, many cancers in India are still detected late, especially those in the digestive system.
2 mins
April 30, 2026
Chronicle Pharmabiz
Telangana appoints DG of DCA as compounding authority
IN a significant move to streamline regulatory compliance under the newly enacted Jan Vishwas provisions, the Government of Telangana has officially designated the Director General (DG) of the state’s Drugs Control Administration (DCA), Shahnawas Quasim, as the 'Compounding Authority'.
2 mins
April 30, 2026
Chronicle Pharmabiz
AIOCD seeks PM's intervention against e-pharmacies
THE All India Organisation of Chemists & Druggists (AIOCD), representing over 12.40 lakh pharmacists and distributors, has formally petitioned Prime Minister Narendra Modi to intervene against the unregulated growth of e-pharmacies and predatory pricing by large corporate entities.
1 mins
April 30, 2026
Chronicle Pharmabiz
Shed The Cavalier Attitude
A Parliamentary Panel has recently asked the Department of Pharmaceuticals (DoP) to take corrective steps to remove any administrative and procedural delays related to the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.
2 mins
April 30, 2026
Chronicle Pharmabiz
DCOIWA slams new DCGI recruitment rules, cites dilution of tech standards
THE Drugs Control Officers (I) Welfare Association (DCOIWA), the national body of drug regulatory officers in the country, has criticised the Union Heath Ministry's newly notified recruitment rules for the post of DCGI, labelling them as a serious policy lapse.
1 mins
April 30, 2026
Chronicle Pharmabiz
Experts highlight the need for data exclusivity to protect MSMES
EXPERTS have highlighted the need for clinical data exclusivity in order to protect MSME drug innovators in India.
2 mins
April 30, 2026
Chronicle Pharmabiz
Mid-sized hospitals in Tier-2 cities stranded in a financial vacuum: Expert
MID-sized hospitals in Tier-2 cities are currently trapped in a financial vacuum. This is because funding usually arrives either too early as venture capital or too late as a financial buyout, said Rakshith Rangarajan, equity fund manager, Inviga Investment Advisors.
2 mins
April 30, 2026
Chronicle Pharmabiz
Indian healthcare sector faces escalating cyber risks
INDIAN healthcare sector is confronting a surge in cyber threats as increasingly complex hospital IT ecosystems create multiple vulnerabilities for potential breaches.
2 mins
April 30, 2026
Listen
Translate
Change font size

